These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28644836)

  • 1. Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.
    Iino C; Shimoyama T; Igarashi T; Aihara T; Ishii K; Sakamoto J; Tono H; Fukuda S
    PLoS One; 2017; 12(6):e0178777. PubMed ID: 28644836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Preoperative Biliary Drainage as a Prognostic Factor After Pancreaticoduodenectomy for Pancreatic Head Cancer.
    Matsumoto M; Nakabayashi Y; Fujiwara Y; Funamizu N; Noaki R; Eto S; Sugano H; Otsuka M; Yanaga K
    Anticancer Res; 2017 Jun; 37(6):3215-3219. PubMed ID: 28551667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction.
    Iwasaki Y; Ishizuka M; Kato M; Kita J; Shimoda M; Kubota K
    World J Surg; 2013 Sep; 37(9):2222-8. PubMed ID: 23657751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-based prognostic score predicts biliary stent patency in patients with unresectable malignant biliary obstruction.
    Iwasaki Y; Ishizuka M; Kato M; Kita J; Shimoda M; Kubota K
    Anticancer Res; 2014 Jul; 34(7):3617-22. PubMed ID: 24982377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy.
    Lamarca A; Rigby C; McNamara MG; Hubner RA; Valle JW
    World J Gastroenterol; 2016 Jul; 22(26):6065-75. PubMed ID: 27468198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.
    Ikuta Y; Takamori H; Sakamoto Y; Hashimoto D; Chikamoto A; Kuroki H; Sakata K; Sakamoto K; Hayashi H; Imai K; Nitta H; Hirota M; Kanemitsu K; Beppu T; Baba H
    Int J Clin Oncol; 2014 Aug; 19(4):629-33. PubMed ID: 23999903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
    Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
    Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
    Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
    Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
    Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
    J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.
    Nakayama M; Tabuchi K; Hara A
    Head Neck; 2015 Dec; 37(12):1745-9. PubMed ID: 24989115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.